metabion completes multi-million euro oligonucleotide capacity expansion in Munich

metabion announced on July 11, 2023 that it has completed a double-digit million euro investment in the first quarter of 2023 to expand its oligonucleotide manufacturing capacity at a new facility in Munich East, Germany. The facility serves diagnostic and therapeutic oligonucleotide production.

“With this investment, we are strengthening our CMO segment and are committed to further expanding our growth area of business.”biopharminternational.com

• 1 source
• biopharminternational.commetabion Expands Oligonucleotide Production Capacity in GermanyJul 14, 2023

Summarized from public sources; check the original articles before acting on it.